Identification of novel genes that are differentially expressed in human colorectal carcinoma

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1407, Issue 3, 1998, Pages 200-204

  Chan, Err Cheng ^a   Lue, Min Yong ^a   Hsu, Kung Cheng ^b   Fan, Hong Arh ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Colorectal tumor; mRNA differential display; Reverse transcriptase polymerase chain reaction; Tissue inhibitor of metalloproteinase 3

Indexed keywords

COMPLEMENTARY DNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL;

AGED; BASE SEQUENCE; BLOTTING, NORTHERN; COLORECTAL NEOPLASMS; DNA, COMPLEMENTARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 0032412603     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(98)00041-6     Document Type: Article

References (23)

1. J.D. Crissman, K.W. Barwick, in: H.J. Wanebo (Ed.), Colorectal Cancer, Mosby-Year Book, St. Louis, MO, 1990, pp. 57-74.
2. Mandel J.S., Bond J.H., Church T.R. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N. Engl. J. Med. 328:1993;1365-1371.
3. Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., vanTuinen P., Ledbetter D.H., Barker D.F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:1989;217-221.
4. Bos J.L. The ras gene family and human carcinogenesis. Mutation Res. 195:1988;255-271.
5. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
6. Hamilton S.R. The molecular genetics of colorectal neoplasia. Gastroenterology. 105:1993;3-7.
7. Kerr I.B., Lee F.D., Quintanilla M., Balmain A. Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumors of the colorectum. Br. J. Cancer. 52:1985;695-700.
8. Morrin M., Kelly M., Barrett N., Delaney P. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut. 35:1994;1627-1631.
9. Shibata D., Schaeffer J., Li Z.H., Capella G., Perucho M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J. Natl. Cancer Inst. 85:1993;1085-1093.
10. Goldstein L.J., Galskin H., Fojo A., Willingham M., Lai S.L., Pirker R., Green A., Crist W., Brodeur G.M. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81:1989;116-174.
11. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
12. Liang P., Averboukh L., Pardee A.B. Distribution and cloning of eukaryotic mRNAs by means of differential display refinements and optimization. Nucleic Acids Res. 21:1993;3269-3275.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Silbiger S.M., Jacobsen V.L., Cupples R.L., Koski R.A. Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene. 141:1994;293-297.
15. Uria J.A., Ferrando A.A., Velasco G., Freije J.M.P., Lopez-Otin C. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res. 54:1994;2091-2094.
16. Matrisian L.M. The matrix-degrading metalloproteinases. BioEssays. 14:1992;455-463.
17. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
18. Khokha R., Zimmer M.J., Wilso S.M., Chambers A.F. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin. Exp. Metast. 10:1992;365-370.
19. DeClerck Y.A., Perez N., Shimada H., Boone T.C., Langley K.E., Taylor S.M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52:1992;701-708.
20. Khokha R., Waterhouse P., Lala P., Zimmer M., Denhardt D.T. Increased proteinase expression during tumor progression of cell lines down-modulated for TIMP levels: a new transformation paradigm. J. Cancer Res. Clin. Oncol. 117:1991;333-338.
21. Ruiz A., Brett P., Bok D. TIMP-3 is expressed in the human retinal pigment epithelium. Biochem. Biophys. Res. Commun. 226:1996;467-474.
22. Sun Y., Kim H., Parker M., Stetler-Stevenson W.G., Colburn N.H. Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells: identification of a transfectant with increased tumorigenicity and invasiveness. Anticancer Res. 16:1996;1-7.
23. Bian J., Wang Y., Smith M.R., Kim H., Jacobs C., Jackman J., Kung H.F., Colburn N.H., Sun Y. Suppression of in vivo tumor growth and induction of suspension cell death ty tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis. 17:1996;1805-1811.